Other
Diarrhoea
6
Pipeline Programs↗
1
Active Trials↗
3
Companies Involved↗
Diarrhoea is an early-stage landscape with 6 programs across 3 companies. The most active players are GSK, Ipsen, Sanofi.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical6
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
13
clinical trials
Completed12 · 92%
Active, not recruiting1 · 8%
Clinical Trials
Trial Activity
13 trials
CMTS4520 for Chronic Diarrhoea in Adults
Active, not recruiting·TThe Second Hospital of Nanjing Medical University·Phase 1/2·NCT06839586·100 enrolled
Efficacy of Zinc Therapy in Acute Diarrhoea in Young Children
Completed·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Phase 3·NCT00325247·2,050 enrolled
Effect of the Sequestrant Colesevelam in Bile Acid Diarrhoea
Completed·—·Phase 4·NCT03876717·255 enrolled
Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea
Completed·—·Phase 4·NCT03059537·71 enrolled
Immunological and Clinical Responses to Zinc in Children With Diarrhoea
Completed·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Phase 3·NCT00408356·338 enrolled
Llama Antibody, Rotavirus Diarrhoea, Children
Completed·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Phase 2·NCT01259765·176 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)